Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 132

1.

Chronic High-Dose Buprenorphine Does Not Block Subjective High from Diacetylmorphine in a Patient in Heroin-Assisted Treatment.

Vogel M, Köck P, Strasser J, Wiesbeck G, Walter M, Dürsteler KM.

J Psychoactive Drugs. 2019 Sep-Oct;51(4):377-382. doi: 10.1080/02791072.2019.1610200. Epub 2019 May 2.

PMID:
31046631
2.

[Sexual Dysfunction in Primary Health Care].

Gürtler MA, Brunner P, Dürsteler-MacFarland KM, Wiesbeck GA.

Praxis (Bern 1994). 2019 Jan;108(1):23-30. doi: 10.1024/1661-8157/a003172. German.

PMID:
30621544
3.

Early Screening for Posttraumatic Stress Disorder in Inpatient Detoxification and Motivation Treatment: Results and Consequences.

Proescholdt MG, Müller SE, Vogel M, Lang U, Wiesbeck GA, Breit W, Linde A, Walter M, Odenwald M.

Eur Addict Res. 2018;24(3):128-136. doi: 10.1159/000490382. Epub 2018 Jul 3.

PMID:
29969761
4.

[Can the cannabis-prohibition be supported by medical evidence ?]

Zullino D, Thorens G, Ferreira P, Rudolf A, Wiesbeck G, Cattacin S.

Rev Med Suisse. 2018 Jun 6;14(610):1176-1178. French.

PMID:
29877645
5.

Effect of Door-Locking Policy on Inpatient Treatment of Substance Use and Dual Disorders.

Steinauer R, Huber CG, Petitjean S, Wiesbeck GA, Dürsteler KM, Lang UE, Seifert C, Andreeff K, Krausz M, Walter M, Vogel M.

Eur Addict Res. 2017;23(2):87-96. doi: 10.1159/000458757. Epub 2017 Mar 29.

6.

Patients with non-substance-related disorders report a similar profile of childhood trauma experiences compared to heroin-dependent patients.

Schwaninger PV, Mueller SE, Dittmann R, Poespodihardjo R, Vogel M, Wiesbeck GA, Walter M, Petitjean SA.

Am J Addict. 2017 Apr;26(3):215-220. doi: 10.1111/ajad.12512. Epub 2017 Feb 27.

PMID:
28240800
7.

Stability of trauma-related symptoms during acute substance use treatment.

Herzog E, Odenwald M, Proescholdt M, Haubold A, Bohnacker I, Flögel M, Linde A, Müller S, Wiesbeck G, Lang U, Walter M, Vogel M.

J Addict Dis. 2016 Jul-Sep;35(3):161-8. doi: 10.1080/10550887.2015.1127718. Epub 2015 Dec 15.

PMID:
26670631
8.

Abnormal functional integration of thalamic low frequency oscillation in the BOLD signal after acute heroin treatment.

Denier N, Schmidt A, Gerber H, Vogel M, Huber CG, Lang UE, Riecher-Rossler A, Wiesbeck GA, Radue EW, Walter M, Borgwardt S.

Hum Brain Mapp. 2015 Dec;36(12):5287-300. doi: 10.1002/hbm.23011. Epub 2015 Oct 6.

PMID:
26441146
9.

[Psychosocial Treatment of Addictive Disorders--An Overview of Psychotherapeutic Options and their Efficacy].

Walter M, Dürsteler KM, Petitjean SA, Wiesbeck GA, Euler S, Sollberger D, Lang UE, Vogel M.

Fortschr Neurol Psychiatr. 2015 Apr;83(4):201-10. doi: 10.1055/s-0034-1399338. Epub 2015 Apr 20. Review. German.

PMID:
25893493
10.

Increased functional connectivity in the resting-state basal ganglia network after acute heroin substitution.

Schmidt A, Denier N, Magon S, Radue EW, Huber CG, Riecher-Rossler A, Wiesbeck GA, Lang UE, Borgwardt S, Walter M.

Transl Psychiatry. 2015 Mar 24;5:e533. doi: 10.1038/tp.2015.28.

11.

Association between methadone dose and concomitant cocaine use in methadone maintenance treatment: a register-based study.

Baumeister M, Vogel M, Dürsteler-MacFarland KM, Gerhard U, Strasser J, Walter M, Wiesbeck GA, Petitjean SA.

Subst Abuse Treat Prev Policy. 2014 Dec 4;9:46. doi: 10.1186/1747-597X-9-46.

12.

A randomized, controlled trial of combined cognitive-behavioral therapy plus prize-based contingency management for cocaine dependence.

Petitjean SA, Dürsteler-MacFarland KM, Krokar MC, Strasser J, Mueller SE, Degen B, Trombini MV, Vogel M, Walter M, Wiesbeck GA, Farronato NS.

Drug Alcohol Depend. 2014 Dec 1;145:94-100. doi: 10.1016/j.drugalcdep.2014.09.785. Epub 2014 Oct 16.

13.

Normalizing effect of heroin maintenance treatment on stress-induced brain connectivity.

Schmidt A, Walter M, Gerber H, Seifritz E, Brenneisen R, Wiesbeck GA, Riecher-Rössler A, Lang UE, Borgwardt S.

Brain. 2015 Jan;138(Pt 1):217-28. doi: 10.1093/brain/awu326. Epub 2014 Nov 19.

14.

Orbitofrontal response to drug-related stimuli after heroin administration.

Walter M, Denier N, Gerber H, Schmid O, Lanz C, Brenneisen R, Riecher-Rössler A, Wiesbeck GA, Scheffler K, Seifritz E, McGuire P, Fusar-Poli P, Borgwardt S.

Addict Biol. 2015 May;20(3):570-9. doi: 10.1111/adb.12145. Epub 2014 Apr 11.

PMID:
24720731
15.

Opioid maintenance therapy in Switzerland: an overview of the Swiss IMPROVE study.

Besson J, Beck T, Wiesbeck G, Hämmig R, Kuntz A, Abid S, Stohler R.

Swiss Med Wkly. 2014 Mar 31;144:w13933. doi: 10.4414/smw.2014.13933. eCollection 2014.

16.

Altered prefrontal connectivity after acute heroin administration during cognitive control.

Schmidt A, Borgwardt S, Gerber H, Schmid O, Wiesbeck GA, Riecher-Rössler A, Bendfeldt K, Smieskova R, Lang UE, Rubia K, Walter M.

Int J Neuropsychopharmacol. 2014 Sep;17(9):1375-85. doi: 10.1017/S1461145714000297. Epub 2014 Mar 18.

17.

Cannabis use among a sample of 16 to 18 year-old students in Switzerland.

Dammann G, Dürsteler-Macfarland KM, Strasser H, Skipper GE, Wiesbeck GA, Wurst FM.

Psychiatr Danub. 2014 Mar;26(1):56-65.

18.

Pathological gambling induced by dopamine antagonists: a case report.

Grötsch P, Lange C, Wiesbeck GA, Lang U.

J Gambl Stud. 2015 Mar;31(1):295-7. doi: 10.1007/s10899-013-9433-2.

PMID:
24356928
19.

Acute effects of heroin on negative emotional processing: relation of amygdala activity and stress-related responses.

Schmidt A, Borgwardt S, Gerber H, Wiesbeck GA, Schmid O, Riecher-Rössler A, Smieskova R, Lang UE, Walter M.

Biol Psychiatry. 2014 Aug 15;76(4):289-96. doi: 10.1016/j.biopsych.2013.10.019. Epub 2013 Nov 4.

PMID:
24314348
20.

Association of frontal gray matter volume and cerebral perfusion in heroin addiction: a multimodal neuroimaging study.

Denier N, Schmidt A, Gerber H, Schmid O, Riecher-Rössler A, Wiesbeck GA, Huber CG, Lang UE, Radue EW, Walter M, Borgwardt S.

Front Psychiatry. 2013 Oct 21;4:135. doi: 10.3389/fpsyt.2013.00135. eCollection 2013.

21.

Acute effects of heroin on emotions in heroin-dependent patients.

Blum J, Gerber H, Gerhard U, Schmid O, Petitjean S, Riecher-Rössler A, Wiesbeck GA, Borgwardt SJ, Walter M.

Am J Addict. 2013 Nov-Dec;22(6):598-604. doi: 10.1111/j.1521-0391.2013.12025.x. Epub 2013 Apr 11.

PMID:
24131168
22.

A systematic review comparing cognitive-behavioral therapy and contingency management for cocaine dependence.

Farronato NS, Dürsteler-Macfarland KM, Wiesbeck GA, Petitjean SA.

J Addict Dis. 2013;32(3):274-87. doi: 10.1080/10550887.2013.824328. Review.

PMID:
24074193
23.

Reduction in cerebral perfusion after heroin administration: a resting state arterial spin labeling study.

Denier N, Gerber H, Vogel M, Klarhöfer M, Riecher-Rossler A, Wiesbeck GA, Lang UE, Borgwardt S, Walter M.

PLoS One. 2013 Sep 10;8(9):e71461. doi: 10.1371/journal.pone.0071461. eCollection 2013.

24.

Treatment or "high": benzodiazepine use in patients on injectable heroin or oral opioids.

Vogel M, Knöpfli B, Schmid O, Prica M, Strasser J, Prieto L, Wiesbeck GA, Dürsteler-Macfarland KM.

Addict Behav. 2013 Oct;38(10):2477-84. doi: 10.1016/j.addbeh.2013.05.008. Epub 2013 May 22.

PMID:
23770646
25.

Inferior frontal cortex modulation with an acute dose of heroin during cognitive control.

Schmidt A, Walter M, Gerber H, Schmid O, Smieskova R, Bendfeldt K, Wiesbeck GA, Riecher-Rössler A, Lang UE, Rubia K, McGuire P, Borgwardt S.

Neuropsychopharmacology. 2013 Oct;38(11):2231-9. doi: 10.1038/npp.2013.123. Epub 2013 May 15.

26.

Acute effects of intravenous heroin on the hypothalamic-pituitary-adrenal axis response: a controlled trial.

Walter M, Gerber H, Kuhl HC, Schmid O, Joechle W, Lanz C, Brenneisen R, Schächinger H, Riecher-Rössler A, Wiesbeck GA, Borgwardt SJ.

J Clin Psychopharmacol. 2013 Apr;33(2):193-8. doi: 10.1097/JCP.0b013e31828393cb.

PMID:
23422375
27.

Atrial natriuretic peptide, arginine vasopressin peptide and cortisol serum levels in opiate-dependent patients.

Glahn A, Heberlein A, Dürsteler-MacFarland KM, Lenz B, Frieling H, Gröschl M, Wiesbeck GA, Kornhuber J, Bönsch D, Bleich S, Hillemacher T.

Neuropsychobiology. 2013;67(2):111-5. doi: 10.1159/000346110. Epub 2013 Feb 9.

PMID:
23406607
28.

A randomized, controlled, pilot trial of methylphenidate and cognitive-behavioral group therapy for cocaine dependence in heroin prescription.

Dürsteler-MacFarland KM, Farronato NS, Strasser J, Boss J, Kuntze MF, Petitjean SA, Bürki C, Wiesbeck GA.

J Clin Psychopharmacol. 2013 Feb;33(1):104-8. doi: 10.1097/JCP.0b013e31827bfff4.

PMID:
23277248
29.

Cognitive behavioral smoking cessation during alcohol detoxification treatment: a randomized, controlled trial.

Mueller SE, Petitjean SA, Wiesbeck GA.

Drug Alcohol Depend. 2012 Dec 1;126(3):279-85. doi: 10.1016/j.drugalcdep.2012.05.026. Epub 2012 Jun 20.

PMID:
22726914
30.

Association of nerve growth factor and vascular endothelial growth factor A with psychometric measurements of opiate dependence: results of a pilot study in patients participating in a structured diamorphine maintenance program.

Heberlein A, Dürsteler-MacFarland KM, Frieling H, Gröschl M, Lenz B, Bönsch D, Kornhuber J, Wiesbeck GA, Bleich S, Hillemacher T.

Eur Addict Res. 2012;18(5):213-9. doi: 10.1159/000337212. Epub 2012 Apr 20.

31.

[Alcohol and violence: a current review].

Proescholdt MG, Walter M, Wiesbeck GA.

Fortschr Neurol Psychiatr. 2012 Aug;80(8):441-9. doi: 10.1055/s-0031-1282018. Epub 2012 Mar 19. Review. German.

PMID:
22431128
32.

The impact of diacetylmorphine on hypothalamic-pituitary-adrenal axis activity and heroin craving in heroin dependence.

Gerber H, Borgwardt SJ, Schmid O, Gerhard U, Joechle W, Riecher-Rössler A, Wiesbeck GA, Walter M.

Eur Addict Res. 2012;18(3):116-23. doi: 10.1159/000334411. Epub 2012 Jan 24.

PMID:
22286020
33.

Pilot study of the application of magnetic bead protein profiling to the study of biomarkers in addiction research.

Meister L, Alawam K, Dudley E, Taurines R, Müller SE, Walter M, Höppner J, Teipel S, Donev RM, Eckert A, Wiesbeck GA, Thome J.

World J Biol Psychiatry. 2011 Sep;12 Suppl 1:80-4. doi: 10.3109/15622975.2011.598712.

PMID:
21906001
34.

Serum levels of BDNF are associated with craving in opiate-dependent patients.

Heberlein A, Dürsteler-MacFarland KM, Lenz B, Frieling H, Grösch M, Bönsch D, Kornhuber J, Wiesbeck GA, Bleich S, Hillemacher T.

J Psychopharmacol. 2011 Nov;25(11):1480-4. doi: 10.1177/0269881111411332. Epub 2011 Sep 2.

PMID:
21890593
35.

The self-image in borderline personality disorder: an in-depth qualitative research study.

Dammann G, Hügli C, Selinger J, Gremaud-Heitz D, Sollberger D, Wiesbeck GA, Küchenhoff J, Walter M.

J Pers Disord. 2011 Aug;25(4):517-27. doi: 10.1521/pedi.2011.25.4.517.

PMID:
21838566
36.

Prolonged use of benzodiazepines is associated with childhood trauma in opioid-maintained patients.

Vogel M, Dürsteler-Macfarland KM, Walter M, Strasser J, Fehr S, Prieto L, Wiesbeck GA.

Drug Alcohol Depend. 2011 Dec 1;119(1-2):93-8. doi: 10.1016/j.drugalcdep.2011.05.037. Epub 2011 Jun 28.

PMID:
21715105
37.

There is no age limit for methadone: a retrospective cohort study.

Dürsteler-MacFarland KM, Vogel M, Wiesbeck GA, Petitjean SA.

Subst Abuse Treat Prev Policy. 2011 May 18;6:9. doi: 10.1186/1747-597X-6-9.

38.

Patients on injectable diacetylmorphine maintenance have low bone mass.

Dürsteler-MacFarland KM, Kowalewski R, Bloch N, Wiesbeck GA, Kraenzlin ME, Stohler R.

Drug Alcohol Rev. 2011 Nov;30(6):577-82. doi: 10.1111/j.1465-3362.2010.00242.x. Epub 2010 Sep 16.

PMID:
21355904
39.

Alpha-synuclein and heroin craving in opiate-dependent patients on injectable heroin maintenance.

Dürsteler-MacFarland KM, Brugger I, Bönsch D, Schmid O, Kornhuber J, Bleich S, Wiesbeck GA.

Addict Biol. 2012 Sep;17(5):875-86. doi: 10.1111/j.1369-1600.2010.00293.x. Epub 2011 Feb 11.

PMID:
21309955
40.

Optimizing heroin-assisted treatment (HAT): assessment of the contribution of direct ethanol metabolites in identifying hazardous and harmful alcohol use.

Wurst FM, Thon N, Yegles M, Halter C, Weinmann W, Laskowska B, Strasser J, Skipper G, Wiesbeck GA, Dürsteler-Macfarland K.

Drug Alcohol Depend. 2011 May 1;115(1-2):57-61. doi: 10.1016/j.drugalcdep.2010.10.020. Epub 2010 Dec 8.

PMID:
21145180
41.

Affective reactivity in heroin-dependent patients with antisocial personality disorder.

Walter M, Degen B, Treugut C, Albrich J, Oppel M, Schulz A, Schächinger H, Dürsteler-Macfarland KM, Wiesbeck GA.

Psychiatry Res. 2011 May 15;187(1-2):210-3. doi: 10.1016/j.psychres.2010.10.017. Epub 2010 Nov 13.

PMID:
21075454
42.

Criminal recidivism in offenders with personality disorders and substance use disorders over 8 years of time at risk.

Walter M, Wiesbeck GA, Dittmann V, Graf M.

Psychiatry Res. 2011 Apr 30;186(2-3):443-5. doi: 10.1016/j.psychres.2010.08.009. Epub 2010 Sep 9.

PMID:
20826002
43.

Patient suicide: a survey of therapists' reactions.

Wurst FM, Mueller S, Petitjean S, Euler S, Thon N, Wiesbeck G, Wolfersdorf M.

Suicide Life Threat Behav. 2010 Aug;40(4):328-36. doi: 10.1521/suli.2010.40.4.328.

PMID:
20822359
44.

Effects of a single 50% extra dose of methadone on heroin craving and mood in lower- versus higher-dose methadone patients.

Strasser J, Wiesbeck GA, Meier N, Stohler R, Dürsteler-Macfarland KM.

J Clin Psychopharmacol. 2010 Aug;30(4):450-4. doi: 10.1097/JCP.0b013e3181e6df49.

PMID:
20571436
45.

Long-term follow-up of orally administered diacetylmorphine substitution treatment.

Frick U, Rehm J, Zullino D, Fernando M, Wiesbeck G, Ammann J, Uchtenhagen A.

Eur Addict Res. 2010;16(3):131-8. doi: 10.1159/000313335. Epub 2010 Apr 26.

PMID:
20424457
46.

Heroin reduces startle and cortisol response in opioid-maintained heroin-dependent patients.

Walter M, Wiesbeck GA, Degen B, Albrich J, Oppel M, Schulz A, Schächinger H, Dürsteler-MacFarland KM.

Addict Biol. 2011 Jan;16(1):145-51. doi: 10.1111/j.1369-1600.2010.00205.x.

PMID:
20331562
47.

Symptom complaints of patients prescribed either oral methadone or injectable heroin.

Dürsteler-MacFarland KM, Fischer DA, Mueller S, Schmid O, Moldovanyi A, Wiesbeck GA.

J Subst Abuse Treat. 2010 Jun;38(4):328-37. doi: 10.1016/j.jsat.2010.01.008. Epub 2010 Mar 4.

PMID:
20206457
48.

Neural effects of heroin--relation to anxiety stress.

Walter M, Wiesbeck GA, Riecher-Rössler A, Borgwardt SJ.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Jun 30;34(5):816-7. doi: 10.1016/j.pnpbp.2010.01.017. Epub 2010 Jan 28. No abstract available.

PMID:
20114068
49.

Risk factors for suicide attempts in patients with alcohol dependence or abuse and a history of depressive symptoms: a subgroup analysis from the WHO/ISBRA study.

Yaldizli O, Kuhl HC, Graf M, Wiesbeck GA, Wurst FM.

Drug Alcohol Rev. 2010 Jan;29(1):64-74. doi: 10.1111/j.1465-3362.2009.00089.x.

PMID:
20078685
50.

Gender differences in interpersonal problems of alcohol-dependent patients and healthy controls.

Mueller SE, Degen B, Petitjean S, Wiesbeck GA, Walter M.

Int J Environ Res Public Health. 2009 Dec;6(12):3010-22. doi: 10.3390/ijerph6123010. Epub 2009 Dec 1.

Supplemental Content

Loading ...
Support Center